CompletedPhase 3NCT00002539

Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma

Studying Bone sarcoma

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Principal Investigator: Marianne A. Nooij, MD
Leiden University Medical Center
Intervention: filgrastim(biological)
Enrollment: 214 enrolled
Eligibility: 40 years · All sexes
Timeline: 1993

Study locations (16)

Institut Jules Bordet, Brussels (Bruxelles), Belgium
Cliniques Universitaires Saint-Luc, Brussels (Bruxelles), Belgium
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
U.Z. Gasthuisberg, Leuven, Belgium
Aarhus Kommunehospital, Aarhus, Denmark
Rigshospitalet, Copenhagen, Denmark
Centre Eugene Marquis, Rennes, France
Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
Emma Kinderziekenhuis, Amsterdam, Netherlands
Leiden University Medical Center, Leiden, Netherlands
University Medical Center Nijmegen, Nijmegen, Netherlands
Academisch Ziekenhuis Utrecht, Utrecht, Netherlands
Instituto Portugues de Oncologia de Francisco Gentil-Centro de Lisboa, Lisbon, Portugal
King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Institute of Oncology, Ljubljana, Ljubljana, Slovenia
+1 more locations on ClinicalTrials.gov

Collaborators

Medical Research Council

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00002539 on ClinicalTrials.gov

Other trials for Bone sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Bone sarcoma →

← Back to all trials